Susquehanna International Group, LLP Taysha Gene Therapies, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 227,472 shares of TSHA stock, worth $568,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227,472
Previous 142,463
59.67%
Holding current value
$568,680
Previous $246,000
28.46%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TSHA
# of Institutions
127Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$50 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$47 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$42.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$29.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$27.2 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $121M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...